Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Rhabdomyosarcoma 6Wilms Tumor 3Rhabdomyosarcoma, Embryonal 3Sarcoma 2Rhabdomyosarcoma, Alveolar 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Pleuropulmonary blastoma 1Hydatidiform Mole, Invasive 1Histiocytoma, Malignant Fibrous 1Gestational Trophoblastic Disease 1Dermatofibrosarcoma 1Choriocarcinoma 1Beckwith-Wiedemann Syndrome 1

Interventions

Methotrexate 2zimberelimab 1camrelizumab 1apatinib 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Leucovorin 1Ipilimumab 1Drug Therapy 1Dactinomycin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gestational Trophoblastic Disease × Dactinomycin × 1 year × Clear all
NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Peking Union Medical College Hospital

Phase NA Active not recruiting
228 enrolled
Gynecologic

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡